Use of Intraoral Suction and Its Effects on Obstructive Sleep Apnea

Sponsor
VA Boston Healthcare System (U.S. Fed)
Overall Status
Not yet recruiting
CT.gov ID
NCT05489562
Collaborator
Massachusetts Institute of Technology (Other)
40
1
26

Study Details

Study Description

Brief Summary

To learn whether stabilization of the tongue using intraoral suction is tolerable and what effects this approach has on sleep parameters in obstructive sleep apnea.

Condition or Disease Intervention/Treatment Phase
  • Device: Intraoral Suction
N/A

Detailed Description

Patients who are newly diagnosed with moderate OSA or diagnosed with OSA in the past 5 years and who are not compliant with continuous positive airway pressure treatment will be identified from the Boston VA Healthcare Sleep Laboratory database and invited to participate in the study. Those patients interested in participating will be consented and then evaluated for adequate nasal patency and oral dentition to assess their eligibility for the study. This is a pilot study primarily assessing tolerability of using intraoral suction to stabilise the tongue at night as well as its effects on sleep parameters. Target enrollment is 40 patients. Those enrolled will have a digital intra-oral scan performed and a custom-fit mouthguard that can transmit low level intermittent suction fabricated. The participant will wear this mouthguard for up to five consecutive nights. They will complete a survey designed to assess tolerability following five nights of wearing the mouthguard. The participant will then have a two night in-hospital polysomnography performed one night with the mouthguard transmitting suction and a second night with no suction. The outcomes will be measured using the tolerability survey scores and the duration and quality of sleep as measured by polysomnography.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Use of Intraoral Suction and Its Effects on Obstructive Sleep Apnea
Anticipated Study Start Date :
Aug 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Single Arm Mouthguard

Subjects wearing mouthguard to access tolerability and comfort of the device

Device: Intraoral Suction
stabilization of the tongue using intraoral suctioning and its effects on sleep parameters in patients with obstructive sleep apnea (OSA).

Outcome Measures

Primary Outcome Measures

  1. Number of patients reporting adverse events related to use of intraoral suction to stabilize the tongue as assessed by a survey [Up to 16 weeks]

    Tolerability and comfort will be assessed by a survey completed by each study subject. Number of patients reporting moderate or more severe pain related to use of intraoral suction to stabilize the tongue as assessed by a self-reported survey using a 5-point pain scale. The survey will be completed by each study subject after having worn the mouthguard for up to 5 consecutive nights in a row. Moderate to severe pain is classified as a score of 3 or higher.after their having worn the mouthguard for up to 5 consecutive nights in a row

Secondary Outcome Measures

  1. Effect on sleep duration [Up to 16 Weeks]

    Change in sleep duration (minutes) with and without intraoral suction as measured by polysomnography

  2. Effect on sleep quality [Up to 16 Weeks]

    Change in percentage time in rapid eye movement (REM) with and without intraoral suction as measured by polysomnography

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18-75

  • Patients newly diagnosed with OSA or patients diagnosed within the past 5 years who are not compliant with continuous positive airway pressure treatment

  • An Apnea Hypopnea Index in the moderate range (15-30)

  • A body mass index (BMI) less than 40

  • Currently using Continuous positive airway pressure (CPAP) with a documented non-compliance of <4 hours/night for 5 nights per week but have at least used the mouthguard within the month prior to enrollment.

  • Adequate dentition to support a dental retainer

Exclusion Criteria:
  • Evidence of central sleep apnea or concomitant sleep disorder other than OSA

  • Currently using Mandibular Advancement Devices (MAD) or other form of mouth prosthesis to treat OSA

  • Prior surgical treatment for OSA

  • History of Chronic Insomnia

  • History of anatomic nasal obstruction

  • Use of medications that may affect sleep

  • Use of pacemaker or implantable cardioverter-defibrillator (ICD).

  • Immunocompromised (i.e., susceptible to infection).

  • Infected with HIV or Hepatitis B.

  • Open soars/wounds in patient's mouth.

  • Active history of alcohol abuse or IV drug use

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • VA Boston Healthcare System
  • Massachusetts Institute of Technology

Investigators

  • Principal Investigator: Ravi Rasalingam, MD, VA Boston Healthcare System

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Ravi Rasalingam, MD, Cardiologist, VA Boston Healthcare System
ClinicalTrials.gov Identifier:
NCT05489562
Other Study ID Numbers:
  • 1686683
First Posted:
Aug 5, 2022
Last Update Posted:
Aug 5, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 5, 2022